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Escalating resistance of bacteria to antibiotics, 
including macrolides, leads to progressive difficulties 
in treatment of bacterial infections. The problems also 
concern infections caused by opportunistic corynebac-
teria (Ortiz-Perez et al., 2010; Olender, 2013; Alibi et al., 
2007). Resistance to macrolides often results from the 
enzymatic methylation of adenosine of the 23S rRNA 
ribosomal subunit and is encoded by the genes from 
the erm family. The above-described mechanism affects 
resistance to lincosamides and streptogramin B and 
so that it is referred to as the MLSB (Maravic, 2004). 
Phenotypic expression of MLSB resistance can be con-
stitutive or inducible. Strains with constitutive MLSB 
(cMLSBB) resistance are considered resistant to all mac-
rolides, lincosamides and streptogramin  B, whereas 
strains with inducible MLSB (iMLSB) present resistance 
to 14- and 15-member macrolides but appear suscepti-
ble to 16-member macrolides, lincosamides and type B 
streptogramins (Weisblum, 1995). Detection of any of 
these mechanisms eliminates such groups of antibiot-
ics from the therapy. Additionally, resistance to mac-
rolides, lincosamides and streptogramin B may also be 
caused by other mechanisms such as efflux pumps or 
enzymatic inactivation of antibiotics encoded by other 
groups of genes (Roberts et al., 1999; Roberts, 2008). 
Resistance to marcolides, lincosamides, and strep-
togramin B in Corynebacterium spp. is noticeable espe-
cially in clinical multidrug-resistant isolates (Otsuka 
et al., 2006; Ortiz-Perez et al., 2010). Nevertheless, in 
a manuscript published in Microbial Drug Resistance 
in 2014 (Szemraj et al., 2014), we have shown that this 
resistance may also occur in the skin microbiota e.g. 
C. tuberculostearicum or C. jeikeium. Our study covered 
99 strains and confirmed earlier reports that the gene 
responsible for this mechanism in corynebacteria is 
erm(X). During that study we did not find other genes 
whereas other researchers demonstrated existence of 
the erm(B), mef or msr(A) genes in these bacteria (Luna 
et al., 1999; Ojo et al., 2006; Ortiz-Perez et al., 2010).
In the following years we pursued the studies on new 
groups of strains. The aim of the research was pheno-
typic marking of the antibiotic susceptibility and detect-
ing of MLSB resistance mechanism in Corynebacterium 
spp. For the investigation we used 18 strains from skin 
of healthy young men that did not have long-term con-
tact with the healthcare services (natural microbiota) 
and 19 strains from clinical materials (mainly from 
blood, urine and wounds). 
The strains were identified by the MALDI-TOF/
VITEK MS mass spectrometry system (bioMerieux), 
performed in the Synevo laboratory in Łódź, and by the 
Coryne API (bioMerieux) phenotypic method. Among 
the clinical isolates and skin microbiota tested there were 
lipophilic as well as non-lipophilic species. Sensitivity to 
penicillin, tetracycline, erythromycin, clindamycin, gen-
tamycin, ciprofloxacin, trimethoprim/sulfamethoxazole, 
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A b s t r a c t
The subject of the study was phenotypic marking of the antibiotic susceptibility and MLSB resistance mechanism in Corynebacterium spp. 
isolated from human skin (18 isolates) and from clinical materials (19 isolates). The strains were tested for the presence of the erm(A), 
erm(B), erm(C), erm(X), lnu(A), msr(A), msr(B) and mph(C) genes. Clinical isolates showed wide resistance to antibiotics. In 89% clinical 
isolates and 72% skin microbiota a constitutive type of MLSB resistance was found. In 12 clinical isolates the erm(C) gene was detected-eight 
of which had erm(X) as well as erm(C), two harboured erm(X), erm(C) and erm(A) and two demonstrated only erm(C). 
K e y  w o r d s: Corynebacterium spp., erm(C), MLSB, resistance genes
Szemraj M. et al. 1238
tigecycline and linezolid was being marked by the disc 
diffusion method according to the EUCAST guide-
lines. S. pneumoniae ATCC 49619 was used as a control 
strain. In the breakpoints absence, CLSI guidelines for 
Corynebacterium spp. were used. When it was not pos-
sible to apply such criteria, EUCAST guidelines were 
administered as for Staphylococcus spp. Both the induci-
ble and constitutive resistance mechanisms were pheno-
typically determined in compliance with the EUCAST 
guidelines for Staphylococcus species by the application 
of S. aureus ATCC 29213 as the control strain. DNA was 
isolated with the usage of Genomic Mini (A&A Biotech-
nology) commercial set in line with the manufacturer’s 
protocol. PCR was performed by the application of the 
primers (Genomed, Sequencing Laboratory, Poland) 
specific for the erm(A), erm(B), erm(C) (Sutcliffe et al., 
1996), erm(X) (Rosato et al., 2001), mph(C) (Perreten et 
al., 2005), msr(A) (Ojo et al., 2006), msr(B) and lnu(A) 
(Lina et al., 1999) genes. DNA amplification was carried 
out in the thermal cycler (Biometra). PCR were initial-
ized by a denaturation step (5 min at 94°C), followed by 
30 cycles of amplification (denaturation 30 sec at 94°C, 
annealing 30 sec at 46–56°C, DNA chain extension 1 min 
at 72°C), and a final extension step (10 min at 72°C). 
Reaction products were recognized by electrophore-
sis (70V by 1 h) in 1% (w/v) agarose gels with Midori 
Green DNA Stain (NIPPON Genetics EUROPE). For 
the readout of outcomes the CCD camera (Syngen) 
was used. Due to a commercial molecular size mar- 
ker the amplification products sizes were determined 
using DraMix (A&A BIOTECHNOLOGY). C. jeikeium 
K411 (CCUG 27385) harbouring erm(X) and S. epi­
dermidis strains: 3718INL harbouring erm(B) and 
mph(C), 1486IG with erm(A), erm(C) and mph(C) and 
1923KIINL with the msr(A) and lnu(A) genes were used 
as positive controls (Juda, 2010).
Similarly to the former work, the identification of 
strains occurred to be tough. However, by the usage 
of MALDI-TOF mass spectrometry (that was based on 
the analysis of the protein profiles of the tested strains) 
and phenotypic methods we managed to identify most 
of the tested strains i.e. 17 clinical isolates and 13 iso-
lates of skin microbiota. None of genetic methods was 
applied. For the Corynebacterium spp., the sequencing of 
the 16S rRNA subunit gene limits the low polymorphism 
of such sequence between species. Thus, sequencing the 
rpoB gene is the only possibility (Khamis et al., 2004). 
Among clinical isolates C. striatum and C. jeikeium pre-
vailed, while among the skin microbiota C. tuberculo­
stearicum and C. jeikeium predominated. C. jeikeium, 
similarly to other corynebacteria, is often described as 
the cause of infection and less often as a sample contam-
ination (Wang et al., 2001; Akan et al., 2002; Mookadam 
et al., 2006). C. jeikeium and C. striatum were isolated 
from endocarditis, bones, joints, lungs, cerebrospinal 
and bacteremia (Lee et al., 2005; Tleyjeh et al., 2005; Bel-
mares et al., 2007; Chen et al., 2012; Daisuke et al., 2017).
The clinical isolates (especially C. striatum, C. amy­
colatum and C. jeikeium) showed a wide resistance to 
antibiotics. All strains from this group were resistant 
to at least three antibiotics (Fig. 1), nine strains to six 
antibiotics and five to seven antibiotics (three strains 
of C. striatum, one of C. amycolatum/xerosis and one 
of C. glucuronolyticum).
Soriano et al. (1995), Reddy et al. (2012) and Hahn 
et al. (2016) also pointed out the growing resistance of 
corynebacteria isolated from clinical materials. Among 
the skin microbiota five strains were sensitive to all 
tested antibiotics whereas the others were resistant to 
at least two up to six antibiotics. All strains from both 
groups were sensitive to linezolid and tigecycline. Simi-
lar Corynebacterium spp. sensitivity to these antibiotics 
was also presented by Morata et al. (2014), Tang et al. 
(2015) and Alibi et al. (2007). The constitutive type of 
MLSB resistance was demonstrated in 17 strains tested 
from clinical specimens (89%) while the other two iso-
Fig. 1. Percentage of strains resistant to two or more antibiotics among skin microbiota and clinical isolates.
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lates were resistant to one from two antibiotics. This 
resistance was accompanied by the erm(A), erm(C) and 
erm(X) genes – individually or in groups. The erm(B), 
msr(A), msr(B), mph(C) and lnu(A) genes were not 
found in the genomes of any of the strains tested. The 
constitutive MLSB resistance mechanism was also dem-
onstrated in 13 resistant strains isolated from healthy 
human skin (72%). These strains were harboring only 
the erm(X) gene what has confirmed our previous 
observations (Szemraj et al., 2014).
It draws the attention that we detected for the first 
time a large number of clinical isolates of Corynebac te­
rium spp. which alongside with the commonly described 
genes such as erm(X) (Olender and Niemcewicz, 2010; 
Olender, 2013) were harbouring also erm(C). In two iso-
lates, three genes: erm(X), erm(C) and erm(A) simulta-
neously existed. In other two isolates (the first resistant 
to macrolide and lincosamides and the second only to 
macrolide), solely erm(C) was detected (Table I). 
These results indicate the importance of this gene 
in the spreading of MLSB resistance mechanism in 
Corynebacterium spp. which until now has not been 
frequently sought in corynebacteria in spite of the fact 
that it is often found in staphylococci (Chaieb et al., 
2007; Cetin et al., 2010).
The results obtained show that clinical strains 
derived from the strains accounting for natural micro-
biota easily acquire new antibiotic resistance genes. The 
fact mentioned above was proven by the resistance pro-
file of the strains tested including genes that provide 
resistance to MLSB antibiotics. There is a possibility of 
horizontal gene transfer in these bacteria what can be 
suggested by the different location of the erm(X) gene 
in the Corynebacterium spp. In C. diphteriae it is a part 
of 14.5 kpz the plasmid pNG2, in C. xerosis this gene is 
a part of the Tn5432 transposon located on the 50 kbp 
Ptp10 plasmid, whereas in C. jeikeium and C. striatum 
it is often located on the Tn5432 transposon inside the 
chromosome (Roberts et al., 1992; Tauch et al., 1995, 
2003, 2005; Rosato et al., 2001). Tn5432 transposon har-
boring erm(X) is also found in other Propionibacterium 
spp. (Ross et al., 2002; El-Mahdy et al., 2010). Our find-
ing of the erm(C) gene among Corynebacterium spp. 
that is responsible for the MLSB mechanism mainly in 
coagulase-negative staphylococci, indicates the poten-
tial for gene acquisition by clinical strains from these 
bacteria (Chaieb et al., 2007; Gatermann et al., 2007; 
Cetin et al., 2010). 
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